Vaseretic

   
Google
 
Web NewDrugInformation.com

Vaseretic


Drug - Vaseretic
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Enalapril Maleate; Hydrochlorothiazide
Multiple ingredients are in alphabetical order.

Strength - 10MG;25MG
The potency of the active ingredient(s), Enalapril Maleate; Hydrochlorothiazide. May repeat for multiple part products.

Applicant - BIOVAIL LABS INTL
The firm name holding legal responsibility for Vaseretic. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019221
The FDA assigned number to Vaseretic. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Vaseretic. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 31, 1986
The date Vaseretic was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Vaseretic. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Vaseretic is in. Format is RX, OTC, DISCN.

Applicant Full Name - Biovail Laboratories International Srl
The full name of the firm holding legal responsibility for the new application of Vaseretic.

Vaseretic